(Q51348247)

English

Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.

scientific article published on 30 November 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

author name string

Feng Ling Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Li Qin Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Feng Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Ling Na Zhu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Ming Cai

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Wei Wei

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

publication date

30 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Molecular Biology Reports

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

40

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

2405-2418

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Epidemiology of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Proteinuria in diabetic kidney disease: a mechanistic viewpoint

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Efficacy of berberine in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Traditional chinese medicine in treatment of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Rodent models of streptozotocin-induced diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Diabetes is an inflammatory disease: evidence from traditional Chinese medicines

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Kidney involvement in a nongenetic rat model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

The pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

A glimpse of various pathogenetic mechanisms of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Physiological roles of G protein-coupled receptor kinases and arrestins

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Activation of tyrosine kinase of EGFR induces Gbetagamma-dependent GRK-EGFR complex formation.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

G-protein-coupled receptor kinase activity is increased in hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

G Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

G protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Phosphorylation-independent attenuation of GPCR signalling

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Renal Endothelin System in Diabetes: Comparison of Angiotensin-Converting Enzyme Inhibition and Endothelin-A Antagonism

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-2321-5

21 January 2018

Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factor-kappaB and protein kinase C

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative stress reduces renal dopamine D1 receptor-Gq/11alpha G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy].

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of aminoguanidine and vitamin C on collagen type IV in diabetic nephropathy rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23196710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11033-012-2321-5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/23196710

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51348247&oldid=2210825684"